Important remarks on the information on the "Temporary authorisation to use medicinal products in accordance with Article 9b paragraph 1 HMG" of 13.3.2019


The information published by swissethics on 13.3.2019 is aimed at pharmaceutical companies, i.e. sponsors who can apply for a temporary authorisation for their drug under certain conditions.
If a non-approved medicinal product is used in an individual case (named patient regulation), the cantonal pharmacist – and no longer Swissmedic as in the past – is solely responsible (import authorisation).

swissethics gladly answers any questions you may have regarding the temporary authorization. Further information can also be found on the Swissmedic website.